SCHEMBL9501938

SCHEMBL9501938

CS(=O)(=O)Nc1ccccc1C(=O)C1CCCCC1

nearest known ligand 0.54

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.54
ALDH1A1 P00352 9/20 0.50
KDM4E B2RXH2 8/20 0.50
HSD17B10 Q99714 7/20 0.50
HPGD P15428 6/20 0.50
TSHR P16473 3/20 0.50
RCE1 Q9Y256 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
HTT P42858 2/20 0.46
MEN1 O00255 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
RXFP1 Q9HBX9 1/20 0.44
P2RX7 Q99572 2/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8918097 0.85 HTR1F (0.50) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL8824695 0.79 ALDH1A1 (0.55) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL9303219 0.77 ALDH1A1 (0.56) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL9502616 0.77 CYP19A1 (0.60) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL4505291 0.76 KMT2A (0.53) KMT2AALDH1A1KDM4EHSD17B10TSHR
SCHEMBL8889074 0.76 KMT2A (0.80) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL4504471 0.75 TSHR (0.52) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL9624375 0.74 KMT2A (0.67) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL220059 0.74 KMT2A (0.72) KMT2AALDH1A1KDM4EHSD17B10HPGD
SCHEMBL9716625 0.73 KDM4E (0.44) KMT2AALDH1A1KDM4EHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0317332-B1 SULFONANILIDE COMPOUNDS TAISHO PHARMACEUTICAL CO. LTD (JP) 1993-05-19 EP disclosed
US-4885367-A ANTIINFLAMMATORY AGENTS, ANTIPYRETICS, ANALGESICS; SIDE EFFECT REDUCTION TAISHO PHARMACEUTICAL CO., LTD. (JP) 1989-12-05 US disclosed
EP-0317332-A2 Sulfonanilide compounds TAISHO PHARMACEUTICAL CO. LTD (JP) 1989-05-24 EP disclosed